Herpes Marker Testing Market

Herpes marker testing is done to detect the presence of the herpes simplex virus (HSV) infection in the body. Various strains of herpes simplex virus have been known to infect humans. Among these, only two are included in the scope of our study: HSV1 and HSV-2. HSV-1 generally causes orofacial diseases such as cold sores, whereas HSV-2 is responsible only for genital herpes. Diagnostic kits available for herpes marker testing include HSV-1 kits, HSV-2 kits and HSV-1/HSV-2 kits.
Herpes Marker Testing Market contains market size and forecasts of Herpes Marker Testing in Global, including the following market information:
Global Herpes Marker Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Herpes Marker Testing market was valued at 76 million in 2021 and is projected to reach US$ 95 million by 2028, at a CAGR of 3.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
HSV-1 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Herpes Marker Testing include Abbott Laboratories, Abcam Plc, BioM?rieux SA, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., Quidel Corporation, Luminex Corporation and Merck KGaA, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Herpes Marker Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Herpes Marker Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Herpes Marker Testing Market Segment Percentages, by Type, 2021 (%)
HSV-1
HSV-2
HSV-1/ HSV-2
Global Herpes Marker Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Herpes Marker Testing Market Segment Percentages, by Application, 2021 (%)
Research
Clinic
Global Herpes Marker Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Herpes Marker Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Herpes Marker Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Herpes Marker Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Abcam Plc
BioM?rieux SA
Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd.
DiaSorin S.p.A.
Quidel Corporation
Luminex Corporation
Merck KGaA
Qiagen N.V.
Norgen Biotek Corp.
Hologic Inc.
Bio Rad Laboratories Inc.
Meridian Bioscience Inc
Teco Diagnostics